Crispr Therapeutics AG (NASDAQ:CRSP) reported earnings of ($0.92) per share missing Walls Streets expectations.

ME Staff
-
0

Crispr Therapeutics AG (NASDAQ:CRSP) reported earnings this Morning, coming in at ($0.92) per share, missing Wall Street’s estimates of ($0.78) per Share. Revenue for the quarter came in at $0.10 million missing the streets estimates of $1.56 million

      Recent Trading for Crispr Therapeutics AG (NASDAQ:CRSP)
      Shares of Crispr Therapeutics AG closed the previous trading session at 34.51 up +2.84 8.97% with 34.1 shares trading hands.